for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reckitt Benckiser Group Plc

RKT.L

Latest Trade

5,523.00GBp

Change

-49.00(-0.88%)

Volume

2,163,989

Today's Range

5,466.00

 - 

5,562.00

52 Week Range

5,466.00

 - 

7,914.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
5,572.00
Open
5,562.00
Volume
2,163,989
3M AVG Volume
22.28
Today's High
5,562.00
Today's Low
5,466.00
52 Week High
7,914.00
52 Week Low
5,466.00
Shares Out (MIL)
714.07
Market Cap (MIL)
39,437.87
Forward P/E
18.55
Dividend (Yield %)
3.16

Next Event

Dividend For RKT.L - 73.0000 GBX

Latest Developments

More

Reckitt Q2 LFL Net Revenue (Ex IFCN China) Was Up 2.2%

Reckitt Partners With Cambridge Centre For Risk Studies In Commitments To Carbon Neutrality

Primavera Capital Acquires Greater China Business Of Mead Johnson From Reckitt Benckiser Group

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Reckitt Benckiser Group Plc

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene, post-natal and home products. The Company's segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN). Health, Hygiene, Home and Portfolio Brands categories are split across the geographical segments of ENA and DVM. Its range of hygiene products includes disinfectant cleaners, automatic dishwashing detergents, pest control, depilatory products and acne treatments. The Company's portfolio of brands includes Durex, Mucinex, Scholl, Strepsils, Cillit Bang, Clearasil, Dettol, Harpic, Lysol, Mortein, Veet, Air Wick, Calgon, Queen V, Vanish and Woolite.

Industry

Personal & Household Prods.

Contact Info

103-105 Bath Road

SL1 3UH

United Kingdom

+44.1753.217800

https://www.rb.com

Executive Leadership

Christopher Alan Sinclair

Non-Executive Chairman of the Board

Laxman Narasimhan

Chief Executive Officer, Executive Director

Jeff Carr

Chief Financial Officer, Executive Director

Kris Licht

President - Health, Global Chief Customer Officer

Aditya Sehgal

President Nutrition, eRB and Greater China

Key Stats

2.09 mean rating - 23 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

12.6K

2019

12.8K

2020

14.0K

2021(E)

13.2K
EPS (GBp)

2018

339.900

2019

349.000

2020

327.000

2021(E)

297.656
Price To Earnings (TTM)
--
Price To Sales (TTM)
2.88
Price To Book (MRQ)
6.02
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
161.88
LT Debt To Equity (MRQ)
107.25
Return on Investment (TTM)
-7.25
Return on Equity (TTM)
-5.27

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up